Lincoln Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue169.34170.59181.47183.08201.54
Expenses133.95141.78146.75166.38153.99
EBITDA39.0832.6638.7420.6651.69
Operating Profit35.6029.0435.0216.9747.81
Profit Before Tax35.3928.8134.7216.7047.55
Net Profit27.6819.9828.6011.6336.23
Financial Ratios
Operating Profit Margin25.37%19.99%23.29%11.03%29.16%
Net Profit Margin17.97%12.23%17.20%6.21%20.44%
Earning Per Share (Diluted)13.829.9814.285.8118.09
Dividends Per Share0.000.000.000.000.00